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AbstrACt
Objectives Conversion is a term for treatments that seek 
to suppress or change a person’s sexual orientation or 
gender. Our review focuses on transgender and gender-
diverse (TGD) people. Our aims were to (1) describe the 
frequency, nature and structure of conversion practices; 
(2) document difficulties in accessing transition-
related healthcare and (3) evaluate the mental health 
consequences of such practices and access barriers.
Method Systematic review and narrative synthesis using 
the Critical Appraisals Skills Programme and Joanne 
Briggs Institute critical appraisal tools. Data sources 
include Embase, MEDLINE, PsychINFO, PsychARTICLES 
and Web of Science between 1990 and June 2017.
Participants Studies were included that (1) document 
use of conversion therapies or access barriers to 
transition-related healthcare; and/or (2) describe how 
such therapeutic practices and access barriers have been 
applied and/or (3) evaluate the mental health impacts of 
such therapies and difficulties accessing transition-related 
healthcare. Two reviewers screened papers for eligibility. 
Data were then grouped according to the objectives. 
Narratives and themes were presented per study.
results Seven studies met inclusion criteria. Four reports 
were on ‘realignment’, involving case studies or case 
series. Two involved psychoanalysis, one self-exposure 
therapy and one open-ended play psychotherapy. All 
four studies concerning ‘realignment’ were of poor 
methodological quality. The other three studies explored 
access barriers from the view point of TGD youth, their 
parents and healthcare providers. All papers reported 
access barriers, such as inability to access puberty-
delaying medications. The papers concerning barriers to 
access were of good methodological quality.
Conclusion We found limited published evidence on 
use, nature, structure and/or health consequences of 
conversion therapies and access barriers to transition in 
TGD people. However, reports of restriction to access may 
indicate a more widespread problem. Research is needed 
into TGD people’s experiences of conversion therapy and 
access barriers to transition-related healthcare
trial registration number CRD42017062149.
IntrOduCtIOn 
Transgender and gender diverse (TGD) is 
an umbrella term for people whose gender 
differs from that normatively expected of their 
assigned sex or with the binary conception of 
gender that is common to most cultures.1 It 
has been estimated that TGD people make 
up 0.5%–2.7% of the population in the USA 
depending on the breadth of the definition 
used2 3 and 0.6% in the UK.4 These are likely 
to be underestimates as data on prevalence 
are mostly derived from clinic attendance 
figures such as in the UK Gender Identity 
Services (GIS), a specialist health service for 
TGD people. GIS provides access to psycho-
therapy and interventions to aid transition 
including hormone replacement therapy and 
surgical interventions. Access to GIS is made 
through a referral by a family practitioner or 
other health specialist.5 However, not all TGD 
persons will want or are able to seek access 
to such services.6 Nevertheless, referrals to 
GIS have increased in recent years, possibly 
because of increasing awareness through 
depiction in the media and greater access 
to information on transitioning.6 Previous 
reviews have explored themes relating 
primarily to mental health and prevalence 
of TGD people in the population.2 7 These 
reviews show an increase in prevalence, 
characterised by referrals made to GIS, and 
increases in depression and anxiety disorders 
compared with the general population.
strengths and limitations of this study
 ► Rigorous systematic review methods, including 
searching five databases.
 ► Brings attention to under-researched field of trans-
gender and gender-diverse health.
 ► Lack of inclusion of grey literature.
 ► Challenges in study identification because conver-
sion therapies and access barriers can be variously 
described.
 ► Lack of reach into educational or religious 
establishments.
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Conversion therapies and access barriers to transition-related 
healthcare
Conversion therapy for TGD people is a general term 
to describe treatments that aim to suppress or divert 
affirmed gender; in short to make the person cisgender, 
that is, no longer TGD. In 2015, a Memorandum of 
Understanding against the use of conversion therapies 
in lesbian, gay and bisexual (LGB) people was agreed by 
health professional bodies in the UK, such as the Council 
for Psychotherapy, the Royal College of Psychiatrists and 
NHS England.8 9 In 2017, a revised Memorandum was 
published which extended advice to cover TGD people 
outside of the UK organisations internationally, such as 
the Australian Psychological Society, and the American 
Psychological Association have released position state-
ments on the use of conversion therapies with TGD 
people.10 Although there has been considerable research 
into conversion therapies in LGB people,11–14 much less 
is known about what such therapies in the UK and else-
where may entail for TGD people,15 and how widespread 
such practices might be.
There have been increasing reports in the media of 
poor transition-related healthcare in TGD people. This 
includes conversion therapies in young TGD people and 
options given to TGD adults for conversion interven-
tions.16 One extreme example comes from the USA, where 
the then president, Barack Obama, spoke about Leelah 
Alcorn’s case, a young transgender girl who committed 
suicide in 2015.16 17 Her suicide was attributed to her 
being taken to Christian therapists who told her that her 
affirmed gender was wrong. This case was brought to 
international attention and featured in national newspa-
pers and journals, for example, Time  magazine headlined 
the case as ‘Leelah Alcorn’s Suicide: Conversion Therapy 
Is Child Abuse’. Other examples are also evident in 
media accounts, particularly with regards to TGD youth 
and access to puberty-delaying medications. Puberty-de-
laying medications slow the process of natal sex puberty 
and thus allow TGD youth more time to explore their 
gender before commencing cross-sex hormone replace-
ment therapy.18 Accessing these medications has been 
shrouded in controversy, with media accounts denying the 
benefits of allowing access and other accounts expressing 
the necessity of allowing access.18 19 These reports are 
dominated by a discourse about persistence or desistance 
of gender dysphoria into adulthood20 and little consider-
ation has been made of the concept that denying access 
may constitute a form of conversion therapy, obliging 
those who meet the criteria for a gender dysphoria diag-
nosis to continue physically in their natal sex.
There has been long-standing controversy about the 
use of words such as ‘desistance’ and ‘persistence’. This 
review acknowledges that so-called desistance has been 
poorly understood because of inadequate study design, 
such as labelling a child as desisting when they were 
no longer contactable, and low participant numbers.21 
The statistic often quoted from desistance literature 
suggests that about 85% of gender-diverse youth, 
including children with diagnosable gender dysphoria, 
will not go on to being gender dysphoric adolescents/
adults.22 23 However, a critical commentary of this has 
been published,24 in which four commonly cited papers 
were reviewed for methodological, theoretical, ethical 
and interpretive concerns.21 23 25 26 The findings suggest 
12 concerns with desistance. The first group was meth-
odological, which included potential misclassifica-
tion of child research participants as dysphoric, lack of 
acknowledgement of social context, age of participants at 
follow-up, potential misclassification of adolescents and 
adults lost to follow-up considered as no longer dysphoric. 
The second was theoretical: assumptions inherent in 
desistance terminology (positioning gender development 
as ‘normal’ or ‘deviant’), binary gender framework (omit-
ting the diversity of gender expression and identities) and 
a presumption of gender stability as a positive outcome. 
The third group were ethical: intensive treatment and 
testing of child participants, questionable goals of treat-
ment (prevention of TGD adolescence and adults) and 
lack of consideration of children’s autonomy. The final 
group was interpretive: an assumption that unknown 
future adult needs should supersede known childhood 
needs and an underestimation of harm when attempting 
to delay or defer transition. The last interpretive concern 
is of direct interest to this review and suggests that with-
holding treatment for TGD youth is more harmful than 
beneficial.
In this paper, we present a review of the published 
research literature on the extent of practice of conver-
sion therapies and barriers to access transition-related 
healthcare, and their mental health consequences. Our 
objectives were as follows:
1. Describe the frequency, nature and structure of con-
version practices.
2. Document the difficulties in accessing transition-relat-
ed healthcare.
3. Evaluate the mental health consequences of such prac-
tices and access barriers.
MethOds
This systematic review is registered with PROSPERO data-
base (CRD42017062149).
definitions and eligibility criteria
We defined conversion as therapies that seek to change 
or suppress a person’s sexual orientation or gender. 
This definition was adapted from conversion efforts in 
LGB people.27 We defined access barriers as attempts 
made to prolong or stop appropriate transition-related 
medication or therapy from occurring by healthcare 
professionals/TGD healthcare gatekeepers. We included 
studies focusing on TGD people that (1) document the 
use of conversion therapies or access barriers to transi-
tion-related healthcare; and/or (2) describe how such 
therapeutic practices and access barriers have been 
applied and/or (3) evaluate the mental health impacts 
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of such therapies and barriers to access. TGD people of 
all ages, both within the UK and worldwide, were eligible 
populations for inclusion. Included was primary research 
written in English in the form of case studies, cross-sec-
tional or cohort studies, case–control studies, qualitative 
studies, randomised clinical trials or other forms of epide-
miological or experimental investigation. With regards to 
barriers, our focus was on intentional/purposeful barriers 
set up by healthcare professionals that aim to reduce or 
halt access to transition-related interventions, that is, 
refusal to refer to specialist services for puberty-delaying 
medication/cross-sex hormones, refusal to offer transi-
tion-related healthcare. This therefore excludes discrim-
ination in a general healthcare context, or barriers to 
help-seeking, as these do not constitute as attempts to 
force natal sex development. We accept that others may 
take our definition as too narrow.
Outcomes
Our main outcomes were evidence of the nature and 
occurrence of conversion therapies and access barriers 
to transition-related healthcare, as well as their mental 
health outcomes, such as depression, anxiety, suicidal 
ideation or attempts.
search strategy
Embase, MEDLINE, PsychoINFO, PsychARTICLES and 
Web of Science were searched from 1 January 1990 to 30 
June 2017. The year 1990 was chosen as we assumed earlier 
research might be at a higher risk of conflating sexual 
orientation and gender identity.28 Search terms selected 
were those used in previous reviews of LGB conversion 
therapy27 and earlier TGD reviews2 7 and examples were 
taken from MEDLINE below. All terms were used in each 
database in the same sequence:
MEDLINE (OVID)
1. (conversion* or reparative* or reorientation* or re-
pair* or barring* or prevent* or affirm* therapy or 
affirm* or non-affirm* or non-affirm* therapy or ac-
cess or maltreatment or refer* or rejection or block*).
mp. [mp=title, abstract, original title, name of sub-
stance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare dis-
ease supplementary concept word, unique identifier, 
synonyms]
2. (transgender or transsexual or gender identity disor-
der or gender dysphoria or GID or cross-dressing or 
intersex or MTF or FTM or gender queer or gender 
non- conforming). mp. [mp=title, abstract, original ti-
tle, name of substance word, subject heading word, 
keyword heading word, protocol supplementary con-
cept word, rare disease supplementary concept word, 
unique identifier, synonyms]
3. 1 AND 2.
Citations were screened by one author (TW), while a 
sample of 200 citations identified randomly were reviewed 
by the other authors to check agreement. Should 
disagreements have been identified, they would have 
been settled by discussion and further samples checked 
until satisfactory agreement had been achieved.
data extraction
Key study data were extracted according to study aim, 
design, participants, intervention type, outcome measures 
and main findings. Extraction was undertaken by TW and 
checked by BC.
data presentation and synthesis
Data from the included studies were grouped according 
to each of our review objectives. We sought to present 
quantitative data in standardised formats, such as mean 
score differences, together with statistical significance 
and confidence levels. A meta-analysis was planned, where 
enough experimental studies were to be found with suffi-
cient homogeneity across them. In the event, however, 
only descriptive accounts were possible. For any qualita-
tive evidence, we sought to present narratives of conver-
sion approaches in relation to our research objectives. 
This approach was chosen due to the narrative nature 
of the included studies, all of which follow a timed struc-
ture.29 Barriers to access were examined using a thematic 
analytical approach.
Quality assessment of studies
The instruments we used to rate quality of the studies 
were dependent on the design of each study. Assessment 
of study quality for case studies identified was undertaken 
using a Joanna Briggs Institute (JBI) Critical Appraisal 
Tool.30 The JBI critical appraisal tool assesses method-
ological quality using the following eight items: the partic-
ipant’s history, demographics, assessment/diagnostic 
methods, preclinical condition, postclinical condition, 
description of intervention(s), serious adverse events 
and key take home messages. Assessment of study quality, 
for both qualitative, and cohort studies identified, was 
undertaken using tools for the Critical Appraisal Skills 
Programme (CASP).31 32 The CASP was applied to the 
barrier to healthcare papers. The CASP Cohort assesses 
quality on 11 questions using a yes/no/unsure/not appli-
cable score. The CASP Qualitative assesses quality on 10 
questions using a yes/no/unsure/not applicable score. 
These answers were then summed to provide an overall 
picture of quality. If we had identified any randomised 
trials, we would have considered using Cochrane recom-
mended assessment tools. Should we have identified 
other studies using other designs, we would have selected 
recommended instruments by consulting method 
experts. Two authors assessed the quality of each study, 
and should there have been any disagreements in their 
assessments, discussion with the third author would have 
been held to reach a consensus.
Funding
This review did not receive external funding.
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Patient and public involvement
Patients and the public were not involved in the concep-
tion or running of this review.
results
summary of included studies
The search strategy yielded 12 606 citations for screening. 
After the initial screening of citations, 117 were considered 
relevant and full texts retrieved for review. In total, 110 
articles did not meet the eligibility criteria (see figure 1). 
Seven studies fulfilled inclusion criteria. Four were case 
studies of conversion therapy33–36 and three concerned 
barriers to healthcare for gender transition.37–39
Conversion therapies
Three of the four studies on conversion therapies origi-
nated from the USA and Canada, and one from the U.K. 
They were published between 1997 and 2012. The ther-
apies used in conversion were psychoanalysis, self-expo-
sure therapy and open-ended play psychotherapy. The 
two psychoanalytic case studies, one self-exposure therapy 
study and one open-ended play psychotherapy presented 
longitudinal data in a qualitative research design. Key 
characteristics of these studies are detailed in tables 1 and 
2.
Three studies were overall of poor methodological 
quality and one was of good methodological quality (see 
table 3). Of the poor designs, none used appropriate 
diagnostic tests or assessment methods of gender either 
before or after the intervention. The type of intervention 
was stated in broad terms (ie, psychoanalysis or self-ex-
posure therapy), but the procedures were not described 
in two of the studies.33 34 Two did not clearly describe 
the details on identification as transgender.33 34 Of the 
good design, preclinical and postclinical condition was 
given and good detail given on the assessments and treat-
ments. All gave a case timeline, some demographics and 
a conclusion.
Case study 1: Andy
Zienst33 describes a 7-year-old assigned male at birth 
who was brought to the psychodynamic therapist by the 
Figure 1 Flow chart of the studies retrieved using the search terms and strategy.
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mother. The reason for this was that a friend’s mother 
instructed her son not to play with Andy due to Andy’s 
‘coquettishly pretending he was a girl’. Zienst highlights 
Andy’s physical appearance, reporting that he had a 
‘short stature’ and was ‘physically less developed than 
the other boys’. Zienst uses only masculine pronouns 
despite Andy’s initial desire to transition, evidenced by 
the following quotes: ‘he freely talked about his wishes 
Table 1 Descriptive display of psychotherapeutic conversion therapies
Study title, author 
and year
Participant 
information Aims Intervention type Outcome measures Main findings Follow-up
Andy: A boy who 
thought he needed to 
be a girl, Zienst, A.B 
(2003)33
Seven-year-old male 
assigned at birth.
To demonstrate the 
multidetermined 
functions of feminine 
identifications and 
strivings in a boy 
with a diagnosable 
gender identity 
disorder.
Psychoanalysis. None stated. Andy through 
the course of 
psychoanalysis 
‘resolved’ cross-
gender feelings and 
continued life as 
male.
Continued life as 
male, despite having 
anxiety about being 
referred to as ‘gay’.
Gender identity 
disorder in a girl: 
insights from 
adoption, Gilmore, K 
(1995)34
Female assigned 
at birth initially 
presented at age six 
to analyst.
To offer insights 
into gender 
identity disorder 
in girls, through 
the examination of 
aetiological factors.
Psychoanalysis. None stated. Participant’s gender 
was the result 
of disruption in 
attachment from 
mother, impacting 
the oedipal stage of 
development.
Through course of 
analysis a ‘shift’ 
in the fantasy of 
being a boy was 
resolved to feminine 
identifications.
No follow-up.
Four Year Remission 
of transsexualism 
after comorbid 
obsessive compulsive 
disorder improved 
with self-exposure 
therapy, Marks, I.M, 
and Mataix-Cols, D. 
(199 7)35
Male assigned at 
birth, identified 
as female since 
15. Presented to 
therapist at 42 with 
OCD, had attended 
GIS since 32/33.
None stated. Self-exposure 
therapy.
None stated. Through therapy, 
63 days later, self-
rated OCD had 
improved by 90%, 
transsexuality and 
homosexuality 
also remitted 
as researchers 
evidenced 
‘masturbation 
three times a week 
to heterosexual 
images’.
By 17 months’ post 
discharge feelings of 
anxiety, depression 
and anxiety were 
98% better and 
identity still male.
At 6 years follow-
up participant’s 
identification as 
transgender had 
‘recurred’ 2 years 
prior. Returned to 
oestrogen 11 months 
prior to follow-up 
and was awaiting 
gender affirmation 
surgery.
A developmental, 
biopsychosocial 
model for the 
treatment of children 
with gender identity 
disorder. Zucker et al 
(2012)36
7  children aged 
under 10 years 
used as clinical 
case examples of 
treatments used by 
Toronto’s gender 
identity clinic to 
resolve gender 
dysphoria in gender 
diverse youth.
To give summary of 
treatment protocols 
by the Centre for 
Addiction and Mental 
Health in Toronto, 
Canada.
To give descriptions 
of assessment 
and multifactorial 
formulation in 
treatment of gender 
dysphoric youth.
Various treatments; 
open-ended play 
psychotherapy.
Parent counselling, 
parent-guided 
interventions 
in naturalistic 
environments, 
psychotropic 
medication for 
co-occurring 
psychopathology.
Based on parent’s 
wishes. If the parent 
wishes for the child 
to be comfortable 
in their natal sex, 
the therapeutic 
intervention is 
centred on this goal.
Prevention of 
transsexualism is 
a treatment goal 
for those who 
are believed to 
‘desist’ from gender 
dysphoria into 
adulthood.
It is of Zucker et al’s 
belief that gender 
identity disorder 
had remitted in the 
majority of their 
clients, through 
the use of their 
interventions.
Mention is made 
of those who did 
go on to transition; 
however, emphasis 
is placed on other 
mental health 
problems and 
addictions.
‘Another natal female 
was originally seen 
for assessment at 
the age of 12 years 
and followed 
up at the age of 
26 … However, he 
struggled with severe 
alcohol abuse, 
abused recreational 
drugs, had been 
frequently arrested 
for getting into fights 
while intoxicated, 
and was occasionally 
suicidal.’
OCD, obsessive compulsive disorder; GIS, Gender Identify Service. 
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to be a girl’ and how the work ‘might take these interests 
from him’. Andy’s identity was described as suppressed 
through psychoanalysis by Zienst by placing emphasis on 
the interactions of Andy’s parents, as well as Andy’s devel-
opment and environment. This resulted in ‘He … told 
me that now he really did want to be a boy because a boy 
didn’t just have to do boy things but could do some girl 
things’. Zienst provided a quasi-follow-up roughly 6 years 
after the course of psychoanalysis, in which Andy phoned 
Zienst during the freshman year at college with worries 
about being called gay.
Case study 2: Samantha
In Gilmore,34 the researcher analyst concludes that 
an adoption that involved living with a new family had 
predisposed the patient to develop a gender identity 
disorder. The young person, Samantha, was removed 
from the foster mother between the age of 6 months and 
1 year due to an adoption taking place. Samantha was 
presented to the analyst at the age of six, after several 
years of ‘preference for maleness’. Gender identity 
disorder was explored through role play and storytelling 
in which Samantha maintained a male role and openly 
Table 2 Descriptive display of barrier papers
Study title, author 
and year
Study design/
participant 
information Aims Outcome measures Main findings Follow-up
Youth and caregiver 
perspectives on 
barriers to gender-
affirming health care 
for transgender youth. 
Gridley et al (2016)37
Qualitative: interviews, 
focus groups and online 
surveys.
15 transgender youth 
aged between 14 and 
22, and 50 parents. 
Majority of participants 
were white (67% and 
78%, respectively)
80% of trans youth 
were too old/ineligible 
for puberty blockers.
To understand barriers 
for transgender youth 
and caregivers in 
accessing healthcare 
services.
None stated. Insurance refusals, delays in 
hormone blockers and cross 
sex hormone prescription, 
inconsistent use of pronoun/
name, few accessible gender 
affirming practitioners, lack 
of consistent protocols, 
uncoordinated care and 
gatekeeping were all factors 
consistent with experiences of 
barriers in healthcare services.
None stated
Health Care providers 
comfort with and 
barriers to care of 
transgender youth. 
Vance et al (2015)38
Survey.
475 members from the 
Society for Adolescent 
Health and Medicine 
and the Pediatric 
Endocrine Society were 
recruited.
To explore provider 
side barriers to giving 
care to TGD youth.
36-item survey 
comprising questions 
on demographic 
information, practice 
characteristics, 
clinical exposure to 
transgender youth 
aged 8–21 years, 
familiarity with and 
adherence to existing 
clinical practice 
guidelines, and 
perceived barriers 
to and comfort and 
confidence with 
providing transgender-
related care.
62% reported feeling 
comfortable providing care 
to TGD people. 6.4% of 
healthcare providers objected 
to treating TGD people 
medically based on religious 
and cultural beliefs.
14.3% reported 
discouragement from 
colleagues.
38% have prescribed 
transgender-related 
medications (puberty blockers/
cross-sex hormones).
Physician-related barriers 
include lack of training, little 
exposure to TGD patients, 
insurance reimbursement 
issues and lack of mental 
health professionals. Despite 
high willingness to offer care.
NA
‘Completely out-
at-sea’ with ‘two-
gender medicine’: a 
qualitative analysis 
of physician-side 
barriers to providing 
healthcare for 
transgender patients. 
Snelgrove et al 
(2012)39
Qualitative: 
semistructured 
interviews, grounded 
theory approach.
13 participants, 9 of 
which were general 
practitioners. 11 
practised in urban or 
small cities whereas 
2 practised in rural 
settings.
To explore physician-
side barriers to the 
provision of care for 
TGD people.
None stated. Physicians perceive significant 
barriers in provision of care 
to TGD youth, uncertainty in 
multiple areas of healthcare 
provision.
Access barriers seen 
when searching for reliable 
information, and during patient 
referral. Patient expectations 
also comprised a barrier, 
with healthcare providers 
feeling that expectations 
were unrealistic and were 
concerned with outcomes of 
transition for the patient.
None stated
NA, not available; TGD, transgender and gender diverse.
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expressed the wish to be a boy. The researcher claimed 
that pre-oedipal disruption of being separated from the 
foster mother had led to a separation anxiety in which a 
male identity was formed as a protection against psychic 
pain. Gilmore claimed that the persistent wish to be the 
other sex, including acquiring parts of the opposite sex, 
was an attempt to resolve these internal conflicts. When 
Samantha was 11, Gilmore states: ‘She then shifted the 
discussion to girls’ potential to be anything, including 
male, by means of a sex change. Here again she defen-
sively avoided feminine success, wishing for a penis to 
complete her body.’ A further 2 years of treatment took 
place, which focused on transference themes arising 
from struggles with the mother figure. It is within these 
2 years that a shift occurred towards a cisgender identity; 
however, the researcher does not make it clear as to what 
was done to facilitate this change. Gilmore claimed that 
the pre-oedipal stage is a time when young girls come to 
understand gender differences, and that gender distur-
bance which first arises in childhood is the result of the 
psychological removal of the mother figure.
Case study 3: anonymous
In a case study by Marks and Mataix-Cols,35 the partici-
pant’s history is more detailed. The participant’s natal 
sex was male, but identification was as female from the 
age of 15. The individual was 42 years of age at the start 
of the study, but had been cross-dressing in feminine 
clothes from the age of 7. She had attended Gender 
Identity Clinics between the ages of 32 and 37 and was 
taking the hormone oestrogen in a bid to affirm her 
desired gender. She had also taken an overdose at the 
age of 16 intending to end her life after a ‘family row 
over his transsexualism and homosexuality’. It is worth 
noting here that the individual was referred specifi-
cally for clinical treatment of her obsessive compulsive 
disorder (OCD) and had refused treatment for ‘trans-
sexualism’. The treatment itself was referred to as self-ex-
posure therapy and was described as ‘self-exposure to 
ritual inducing situations with self-imposed prevention 
of rituals’. Although it was reported as a highly effective 
treatment for depression, anxiety and OCD, the authors 
also claimed to have shifted the patient’s gender identity 
towards cisgender. However, at 6 years follow-up, it was 
reported that the participant had returned to the clinic 
dressed as a woman, having started 2 years earlier, and 
was awaiting gender affirmation surgery, having taken 
oestrogens for 11 months.
Table 3 Summary of the methodological quality of the conversion therapy studies
Zienst33 Gilmour34
Marks and Mataix-
Cols35 Zucker et al 36
1. Were the patient’s 
demographics clearly 
described?
Yes Yes Yes Yes
2. Was the patient’s history 
clearly described and 
presented as a timeline?
Yes Yes Yes Yes
3. Was the current clinical 
condition of the patient 
on presentation clearly 
described?
Not reported Not reported Unclear Yes
4. Were diagnostic tests 
or assessment methods 
and the results clearly 
described?
Unclear NA NA Yes
5. Was the intervention(s) 
or treatment procedure(s) 
clearly described?
No details on process of 
intervention
No details on process of 
intervention
Yes Yes
6. Was the postintervention 
clinical condition clearly 
described?
NA NA Yes Yes
7. Were adverse events 
(harms) or unanticipated 
events identified and 
described?
Unclear Unclear Yes Yes
8. Does the case report 
provide takeaway lessons?
Yes Yes Yes Yes
NA
NA, not available.
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Case examples 4
In a series of case examples presented from the Centre of 
Addiction and Mental Health in Toronto, Canada,36 seven 
children under the age of 10 were described in terms of 
demographic characteristics, assessment, formulation 
and treatment plan. The paper describes an assessment 
period of 3–4 clinic visits by the gender-diverse youth and 
their primary caregiver. A formulation of the case then 
shaped the treatment goals. This was often led by the 
primary caregiver’s desires for the child,
If the parents are clear in their desire to have their 
child feel more comfortable in their own skin, that 
is, they would like to reduce their child’s desire to 
be of the other gender, the therapeutic approach is 
organized around this goal.
This treatment was often conducted using open-
ended play psychotherapy, where the clinician explores 
gender through dolls and other toys in order to allow a 
gender-diverse child to talk through their gender. Primary 
caregivers are also involved in psychotherapy, exploring 
how their own behaviour may cause and maintain gender 
dysphoria in their child. Primary caregivers would be 
encouraged to put limitations on cross-gender behaviour. 
Zucker et al argued that gender dysphoria is reparable, 
while sexual orientation is not. They argued that despite 
a remission in gender dysphoria in a child repression 
of eventual sexual orientation was not a treatment goal 
offered by the service. The main argument proposed by 
the authors was that of poor psychosocial functioning 
as a TGD adult in those who may have ‘persisted’. The 
argument stemmed from a wish for the gender-diverse 
youth to have a well-functioning adulthood and to be 
comfortable in their own skin. Furthermore, the authors 
estimate their own persistence rate of gender dysphoria 
into adolescence at 12%–14%.
Difficulties in accessing TGD-related healthcare
Three studies on barriers to transition-related healthcare 
were identified.37–39 One was on American TGD youth 
(n=15) and their parents (n=60)37 which used a qualitative 
research design to explore their perspectives on access 
barriers. The other two explored health professionals’ 
knowledge and practice in providing transition-related 
healthcare.38 39 One of these studies gained, via an online 
survey, 475 responses from a multidisciplinary group of 
American professionals who were members of the Society 
for Adolescent Health and Medicine. Of these, 66.5% had 
provided care to transgender youth. The other captured 
the perspectives of 15 American physicians via semistruc-
tured interviews. Using qualitative analysis of the tran-
scripts, the authors explored thematically barriers faced 
by physicians when caring for TGD patients. We found 
these studies overall had good methodological quality 
(see table 4). All had clear research aims and described 
data analysis.
Predominant themes in the paper on TGD people, and 
their parents, with regards to access barriers to transition 
related healthcare,37 indicated difficulties in accessing 
puberty-delaying medications. This was attributed to a 
lack of consistently applied protocols. Further reports 
described patients from whom puberty-delaying treat-
ments had been withheld, despite their meeting the 
criteria for gender dysphoria. Furthermore, larger-scale 
factors played a role in difficulties accessing transition-re-
lated healthcare, such as insurance refusals and a lack of 
knowledgeable providers to turn to for beginning a phys-
ical/medical transition. It was also reported that health-
care providers would use incorrect pronouns and names 
when referring to their TGD patients.
The other studies exploring healthcare providers’ 
views on TGD-related healthcare provision38 39 reported 
that despite a willingness to offer care several difficulties 
were raised. These were uncertainty about exactly what to 
do32; religious conflicts that sometimes posed a barrier to 
providing care (6.4% of 475 healthcare providers refused 
to treat TGD people based on their religious beliefs)31 
and discouragement from colleagues.31 32 Finally, a domi-
nant theme was the absence of access to mental health 
professionals, who could aid in the transition process by 
providing psychological support. Healthcare providers 
described an inability to identify mental health profes-
sionals who specialised in gender dysphoria. In both 
studies, it was apparent that there is a need for further 
training and knowledge in transition-related healthcare.
dIsCussIOn
To our knowledge, this is the first systematic review of 
conversion therapies and access barriers to transition-re-
lated healthcare in TGD people. It aimed to review the 
nature and extent of conversion therapies in TGD people, 
access barriers to transition-related healthcare and the 
mental health consequences of both.
Seven published studies were eligible. Four were on 
specific conversion attempts, in which the treatments 
were poorly described. Although psychoanalysis, expo-
sure therapy and play psychotherapy were used to bring 
about this change, two of the included studies could not 
justify the nature of the therapies used, and none appro-
priately assessed mental health outcomes. The three other 
studies explored access to appropriate transition-related 
treatments. It was clear that difficulties existed not only 
in terms of access to treatments to delay or block puberty 
in TGD youth, but also regarding physicians’ personal 
preparedness to offer treatment or their knowledge about 
directing patients to appropriate specialist care. There 
was no assessment of the mental health consequences of 
such barriers in the studies.
Interpretation
1.  Describe the frequency, nature and structure of conver-
sion practices.
We found limited evidence in the research literature 
of the use of conversion therapies that aimed solely at 
suppressing or modifying what was considered by the 
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therapist as abnormal gender identity. The four case study 
papers identified were published between 1997 and 2012. 
Had our search extended prior to 1990, we would have 
identified more evidence on the practice. However, there 
was a risk historically that the conflation of gender diverse 
with gay and lesbian people would have made identifi-
cation of treatments difficult.28 We are aware of at least 
two papers published before 1990 that describe explicit 
attempts to change the gender of several TGD people.40 41 
These studies both used electric aversion therapy with 
results indicating that no change had occurred. Both arti-
cles were published in the late 1960s and early 1970s, and 
both indicate that conversion approaches in TGD people 
were ineffective.
The treatment approaches took the view that TGD 
people arose from impaired development and inappro-
priate caregiver role models. They echo previous claims 
for the pathological basis of same-sex sexual orientation. 
They were also similar to the practice of LGB conversion 
therapy from the 1960s to the 1980s in which psychody-
namic and behaviour therapies were used.42 Here, however, 
there was no attempt in three of the included studies to 
explain how the therapy was carried out. For example, 
although self-affirmation as transsexual preceded the 
onset of OCD in Marks’s and Mataix-Cols’ case, the 
treatment goal was not only to alleviate the symptoms of 
OCD, but also to alleviate ‘symptoms’ of transsexualism. 
Thus, perhaps it is not surprising that the authors’ final 
remarks are somewhat muddled: ‘This case and others 
show that gender identity and paraphilias can remit for 
years after comorbid OCD and other disorders improve 
with various treatments.’ The paper by Zucker, however, 
did describe how their open-ended play psychotherapy 
was conducted, and their goal was also stated broadly as 
prevention of transsexualism. The authors do not suggest 
reorienting future sexual orientation; however, have 
mirrored previous studies in LGB conversion, particularly 
with regards to behavioural modification.12
Furthermore, with regards to Zucker et al’s paper, we 
are aware of the controversy about his practices, with 
many families and TGD people regarding the work as 
reparative in nature. The authors were not adopting a 
‘watch and wait’ policy but were attempting to reduce 
cross-gender identification. The paper also heavily relies 
on ‘desistance’ statistics. As mentioned previously, a 
recent critical review of desistance literature covers meth-
odological, theoretical, ethical and interpretive concern 
of these follow-up studies.24 It highlights the potential of 
misclassification of children having gender dysphoria, 
the problem of those lost to follow-up being classified 
as a ‘desistor’ and assumptions about grounding in a 
binary gender framework. The commentary also takes a 
stance with regards to regret by suggesting that children 
may perhaps transition again in the future, and that this 
event would be traumatic. While regret is conceivable, it 
is rare, and therefore does not justify the argument that 
gender-diverse youth should be restricted in their gender 
expression.24
2. Document difficulties in accessing transition-related 
healthcare.
In our search, we identified 11 studies of barriers to 
general healthcare encountered by TGD people.37–39 43–49 
However, only three of these studies were suitable for 
inclusion in the review using a strict viewpoint of barriers 
accessing transition-related healthcare.
These studies were all published in the past 5 years and 
and may explain the common perception of TGD people 
that access to what they regard as appropriate healthcare 
is restricted. They suggest evidence of restricting/denial 
of access to transition related healthcare, particularly in 
the case of TGD youth. They also highlight the issue of 
cis-heteronormativity, which assumes TGD people are not 
authentically the gender with which they identify. This 
in turn means that TGD youth and adults risk encoun-
ters with healthcare providers who have assumptions 
about gender and sex that are incongruent with their 
own views. The predominant themes in these studies 
were delayed/postponed healthcare seeking due to the 
barriers encountered. Within TGD youth, the emphasis 
was on an inability to access puberty delaying medica-
tions and hormone replacement therapy. Furthermore, 
reasons for objections to the provision of transition-re-
lated healthcare arose from lack of knowledge, as well 
as the religious/spiritual beliefs, of providers. Although 
research into the psychosocial functioning of TGD youth 
who take puberty-delaying medications shows improve-
ments compared with same-age peers, and a resolution of 
dysphoria related to gender,50 physicians may have uncer-
tainties about starting puberty-delaying treatments in very 
young TGD people.
It is worth noting that gender identity clinics were 
founded on rigid concepts of the ‘true transsexual’, to 
mean a heterosexual person who wishes to transition 
to the opposite sex. Historically, there was no place for 
people with more subtle combinations of gender identi-
fication and sexual orientation, who were often seen as 
unsuitable for transition.51
3. Evaluate the mental health consequences of such 
practices and access barriers.
The mental health consequences of conversion ther-
apies were poorly described and no reports from the 
patients were included. The treatments did not appear 
to lead to any obvious change in their status as TGD 
people. Furthermore, the methodological rigour of the 
included studies was mixed, with three being poor and 
four being good. Most studies did not include partici-
pants’ own accounts and instead relied on the interpre-
tations of the therapists. This is particularly alarming as 
the outcomes of these conversion therapies are based 
on the assumptions made by the therapist as opposed to 
validated measures, such as The Gender Preoccupation 
and Stability Questionnaire (GPRSQ).52 The GRPSQ is 
a tool used to assess gender dysphoria outcomes regard-
less of intervention type, that is, surgical, medical or 
psychological. The lack of validated assessments over 
the follow-up in these studies also suggests that little 
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consideration was made of the benefits or harms of 
such interventions.
In Zucker’s paper, there is a clear focus on the future 
adult’s needs. These future adult needs emphasised the 
risk of social ostracism, and therefore attempting to alter 
gender within children and young people was assumed 
to reduce this risk. No longer-term follow-up data were 
presented that give credence to this approach, which 
ignores how social ostracism is grounded in transphobia 
arising from society as a whole.
There was no mention of mental health impacts in the 
studies on barriers to transition-related healthcare. What 
is known, however, is that TGD affirmative practices are 
associated with positive mental health outcomes.53 Austin 
et al53 reported that transgender cognitive behaviour 
therapy showed good preliminary evidence of effec-
tiveness, with decreases in depression over a 3-month 
follow-up period.
reseArCh COnsIderAtIOns And COnCludIng reMArks
This review identified a research gap within the conver-
sion therapy discourse, namely the prevalence and charac-
teristics of such treatments of TGD people, their current 
form and their mental health consequences. Primary 
research in TGD identified people would seem to be the 
best way forward to answer these questions. However, 
such research would need to cast a wide net to capture 
the experiences of conversion therapies. For example, 
besides talking treatments, verbal and physical harass-
ment by healthcare professionals in the care of TGD 
youth and adults, and gatekeeping in terms of waiting 
lists and referral processing, should be investigated 
with mental health outcomes as a primary concern. Any 
research focusing on conversion therapies would need to 
use a retrospective method due to the ethics surrounding 
conversion practices. Qualitative studies of the experi-
ence of conversion therapy should be undertaken, partic-
ularly to identify the voluntary and involuntary paths 
TGD people took towards any conversion therapy, and 
their experiences during such treatments and beyond. 
Despite our finding evidence of access barriers to tran-
sition-related healthcare for TGD people, longitudinal 
research from a prospective cohort is needed to examine 
(1) how often and how soon access barriers are experi-
enced and (2) the mental health impacts of being denied 
appropriate transition-related healthcare
To an extent our findings are reassuring, in that explicit 
attempts at conversion therapy seem to be less common 
than was the case in LGB people, and erecting barriers 
to transition-related healthcare were also not common. 
However, our results only concern peer-reviewed 
published literature and thus we cannot exclude the 
possibility of conversion treatments and bars on accessing 
treatment in day-to-day clinical practice. Thus, our results 
alert practitioners to the possibilities of such practice and 
how it is inappropriate. Our recommendation is to inves-
tigate the topic further using primary research methods 
in a cross section of TGD people in order to understand 
more about TGD conversion experiences and specific 
access barriers to transition-related healthcare.
Contributors MK conceived the original idea for the review, which was refined 
with the other authors. TW derived the search terms and strategy with assistance 
from BC and MK. TW undertook the review, screening and assessment of papers 
with assistance from BC and MK on inclusion of papers. TW wrote the first draft of 
the paper and all authors contributed to the final version.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors. 
Competing interests Not declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
data sharing statement No technical appendix, statistical code, and/or dataset 
available from the Dryad repository, as this review does not have raw data to share.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Saewyc EM. Respecting variations in embodiment as well as gender: 
Beyond the presumed ‘binary’ of sex. Nurs Inq 2017;24:e12184.
 2. Conron KJ, Scott G, Stowell GS, et al. Transgender health in 
Massachusetts: results from a household probability sample of 
adults. Am J Public Health 2012;102:e20171683.
 3. Reed B, Rhodes S, Schofield P, et al. Gender variance in the UK: 
Prevalence, incidence, growth and geographic distribution. 2011. 
http:// worldaa1. miniserver. com/~ gires/ assets/ Medpro- Assets/ 
GenderVarianceUK- report. pdf
 4. Ellis SJ, Bailey L, McNeil J. Trans people’s experiences of mental 
health and gender identity services: a UK Study. J Gay Lesbian Ment 
Health 2015;19:4–20.
 5. Arcelus J, Bouman WP, Van Den Noortgate W, et al. Systematic 
review and meta-analysis of prevalence studies in transsexualism. 
Eur Psychiatry 2015;30:807–15.
 6. Chen M, Fuqua J, Eugster EA. Characteristics of referrals for gender 
dysphoria over a 13-Year Period. J Adolesc Health 2016;58:369–71.
 7. Dhejne C, Van Vlerken R, Heylens G, et al. Mental health and 
gender dysphoria: A review of the literature. Int Rev Psychiatry 
2016;28:44–57.
 8. England NHS, Scotland NHS. The Scottish Government… et al. 
Memorandum of understanding on conversion therapy in the UK. 
2015 https://www. psychotherapy. org. uk/ wp- content/ uploads/ 2016/ 
09/ Memorandum- of- understanding- on- conversion- therapy. pdf.
 9. Strudwick P. Trans therapists sign open letter to mental health body 
over conversion therapy [internet]. 2017 https://www. buzzfeed. com/ 
patrickstrudwick/ trans- therapists- sign- open- letter- to- mental- health- 
body- over? utm_ term=. kf7QXgXL3z#. byBQlelZ2R (Accessed 20 Jul 
17).
 10. Substance Abuse and Mental Health Services Administration, Ending 
Conversion Therapy. Supporting and Affirming LGBTQ Youth. HHS 
Publication No. (SMA) 15-4928. Rockville, MD: Substance Abuse and 
Mental Health Services Administration, 2015.
 11. Haldeman DC. The practice and ethics of sexual orientation 
conversion therapy. J Consult Clin Psychol 1994;62:221–7.
 12. Throckmorton W. Efforts to modify sexual orientation: a review of 
outcome literature and ethical issues. Journal of Mental Health 
Counseling 1998;20:283.
 13. Dehlin JP, Galliher RV, Bradshaw WS, et al. Psychosocial correlates 
of religious approaches to same-sex attraction: a mormon 
perspective. J Gay Lesbian Ment Health 2014;18:284–311.
 14. Dehlin JP, Galliher RV, Bradshaw WS, et al. Sexual orientation change 
efforts among current or former LDS church members. J Couns 
Psychol 2015;62:95–105.
 15. Premier Christianity. Why I voted against the ‘conversion therapy’ 
ban and transgender motions at Synod. 2017 https://www. 
premierchristianity. com/ Blog/ Why- I- voted- against- the- conversion- 
12 Wright T, et al. BMJ Open 2018;8:e022425. doi:10.1136/bmjopen-2018-022425
Open access 
therapy- ban- and- transgender- motions- at- Synod( acessed on 
30.11.2018).
 16. Fox F. Leelah alcorn’s suicide: conversion therapy is child abuse. 
2015 http:// time. com/ 3655718/ leelah- alcorn- suicide- transgender- 
therapy/ (accessed on 9.08.2017).
 17. Shear MD. Obama calls for end to ‘conversion therapies for gay and 
transgender youth. The New York Times, 2015.
 18. Kaiser Health News. Can delaying puberty help transgender kids? 
2016 https://www. thedailybeast. com/ can- delaying- puberty- help- 
transgender- kids (Accessed on 13 Jan 2018).
 19. Anderson R. New paper says puberty blockers aren’t the answer 
to gender confusion. 2017 http:// dailysignal. com/ 2017/ 06/ 20/ 
new- paper- says- puberty- blockers- arent- answer- gender- confusion/ 
(Accessed on 13 Jan 2018).
 20. Growing Up Transgender. The end of the ‘desistance’ myth. 2017 
https:// growinguptransgender. wordpress. com/ 2017/ 12/ 03/ the- end- 
of- the- desistance- myth/ (Accessed on 13 Jan 2018).
 21. Wallien MS, Cohen-Kettenis PT. Psychosexual outcome of 
gender-dysphoric children. J Am Acad Child Adolesc Psychiatry 
2008;47:1413–23.
 22. Zucker KJ. On the “natural history” of gender identity disorder in 
children. J Am Acad Child Adolesc Psychiatry 2008;47:1361–3.
 23. Drummond KD, Bradley SJ, Peterson-Badali M, et al. A follow-
up study of girls with gender identity disorder. Dev Psychol 
2008;44:34–45.
 24. Temple Newhook J, Pyne J, Winters K, et al. A critical commentary 
on follow-up studies and “desistance” theories about transgender 
and gender-nonconforming children. International Journal of 
Transgenderism 2018;19:212–24.
 25. Steensma TD, Biemond R, de Boer F, et al. Desisting and persisting 
gender dysphoria after childhood: a qualitative follow-up study. Clin 
Child Psychol Psychiatry 2011;16:499–516.
 26. Steensma TD, Cohen-Kettenis PT. Gender transitioning before 
puberty? Arch Sex Behav 2011;40:649–50.
 27. Serovich JM, Craft SM, Toviessi P, et al. A systematic review of the 
research base on sexual reorientation therapies. J Marital Fam Ther 
2008;34:227–38.
 28. Valdes F. Queers, sissies, dykes, and tomboys: deconstructing the 
conflation of “sex,” “gender,” and “sexual orientation” in euro-
american law and society (Doctoral dissertation, Stanford Law 
School) 1994.
 29. Riessman CK. Narrative analysis: University of Huddersfield, 2005.
 30. The Joanna Briggs Institute. Joanna briggs institute 
reviewers’ manual: 2016 edition. Australia: The Joanna Briggs 
Institute, 2016.
 31. Critical Appraisal Skills Programme. CASP Qualitative research. 2017 
http://www. casp- uk. net/ casp- tools- checklists (cited 7 Jan 2018).
 32. Critical Appraisal Skills Programme. CASP Cohort research. 2017 
http://www. casp- uk. net/ casp- tools- checklists (cited 7 Jan 2018).
 33. Zients AB. Andy. A boy who thought he needed to be a girl. 
Psychoanal Study Child 2003;58:19–34.
 34. Gilmore K. Gender identity disorder in a girl: insights from adoption. J 
Am Psychoanal Assoc 1995;43:39–59.
 35. Marks IM, Mataix-Cols D. Four-year remission of transsexualism 
after comorbid obsessive-compulsive disorder improved with self-
exposure therapy. Case report. Br J Psychiatry 1997;171:389–90.
 36. Zucker KJ, Wood H, Singh D, et al. A developmental, 
biopsychosocial model for the treatment of children with gender 
identity disorder. J Homosex 2012;59:369–97.
 37. Gridley SJ, Crouch JM, Evans Y, et al. Youth and caregiver 
perspectives on barriers to gender-affirming health care for 
transgender youth. J Adolesc Health 2016;59:254–61.
 38. Vance SR, Halpern-Felsher BL, Rosenthal SM. Health care providers’ 
comfort with and barriers to care of transgender youth. J Adolesc 
Health 2015;56:251–3.
 39. Snelgrove JW, Jasudavisius AM, Rowe BW, et al. “Completely 
out-at-sea” with “two-gender medicine”: a qualitative analysis of 
physician-side barriers to providing healthcare for transgender 
patients. BMC Health Serv Res 2012;12:110.
 40. Bancroft J, Marks I. Treatment of sexual deviations: electric 
aversion therapy of sexual deviations. Proc Roy Soc Med 
1968;61:30–2.
 41. Marks I, Gelder M, Bancroft J. Sexual deviants two years after 
electric aversion. Br J Psychiatry 1970;117:173–85.
 42. Flentje A, Heck NC, Cochran BN. Experiences of ex-ex-gay 
individuals in sexual reorientation therapy: reasons for seeking 
treatment, perceived helpfulness and harmfulness of treatment, and 
post-treatment identification. J Homosex 2014;61:1242–68.
 43. Kattari SK, Walls NE, Speer SR. Differences in experiences of 
discrimination in accessing social services among transgender/
gender nonconforming individuals by (Dis)ability. J Soc Work Disabil 
Rehabil 2017;16:116–40.
 44. Costa AB, da Rosa Filho HT, Pase PF, et al. Healthcare needs of and 
access barriers for brazilian transgender and gender diverse people. 
J Immigr Minor Health 2018;20:115–23.
 45. White Hughto JM, Murchison GR, Clark K, et al. Geographic and 
individual differences in healthcare access for u.s. transgender 
adults: a multilevel analysis. LGBT Health 2016;3:424–33.
 46. Safer JD, Coleman E, Feldman J, et al. Barriers to healthcare for 
transgender individuals. Curr Opin Endocrinol Diabetes Obes 
2016;23:168–71.
 47. Jaffee KD, Shires DA, Stroumsa D. Discrimination and delayed 
health care among transgender women and men: implications for 
improving medical education and health care delivery. Med Care 
2016;54:1010–6.
 48. Cruz TM. Assessing access to care for transgender and gender 
nonconforming people: a consideration of diversity in combating 
discrimination. Soc Sci Med 2014;110:65–73.
 49. Hussey W. Slivers of the journey: the use of photovoice and 
storytelling to examine female to male transsexuals’ experience of 
health care access. J Homosex 2006;51:129–58.
 50. de Vries AL, McGuire JK, Steensma TD, et al. Young adult 
psychological outcome after puberty suppression and gender 
reassignment. Pediatrics 2014;134:696–704.
 51. Transgender History in the United States. A special unabridged 
version of a book chapter from Trans Bodies, Trans Selves: 
Transgender History in the United States. https://www. umass. edu/ 
stonewall/ sites/ default/ files/ Infoforandabout/ transpeople/ genny_ 
beemyn_ transgender_ history_ in_ the_ united_ states. pdf
 52. Hakeem A, Črnčec R, Asghari-Fard M, et al. Development and 
validation of a measure for assessing gender dysphoria in adults: 
the gender preoccupation and stability questionnaire. International 
Journal of Transgenderism 2016;17:131–40.
 53. Austin A, Craig SL, D'Souza SA. An AFFIRMative cognitive 
behavioral intervention for transgender youth: Preliminary 
effectiveness. Professional Psychology: Research and Practice 
2018;49:1–8.
